China's Covid-19 lockdown: What happened next?
China鈥檚 latest Covid-19 wave could rise to 65 million but lockdowns look unlikely. Low cost meningitis vaccine are being trialled in Mali and Gambia.
When China abruptly ended its tough lockdown policy in December 2022, Covid cases in the country rose rapidly. The Government鈥檚 official death toll was 121,000, but medical epidemiologist Ray Yip is one of several experts estimating it could have been much higher. Now China is experiencing another wave of Covid-19 fuelled by the Omicron variant, but this time the nation seems determined to continue with normal life. Claudia Hammond speaks to journalist Cindy Sui who has interviewed Chinese people about how authorities are handling the virus.
Claudia investigates the rise of medical journals and events, which might not be what they first appear. So called 鈥榩seudo-journals' have even been known to accept complete fiction.
She is also joined by professor of Epidemiology at Boston University Matt Fox to discuss recent trials of a new low cost meningitis vaccine in Mali and The Gambia. If rolled out it could protect against the five main meningococcal strains found in Africa. And a new way of detecting dangerous blood loss after birth. A randomised trial shows a plastic drape, costing between 1 and 2 US dollars might significantly lower the number of deaths by post-partum haemorrhage.
Image Credit: Getty Images
Presenter: Claudia Hammond
Producer: Clare Salisbury
Assistant producer: Jonathan Blackwell
Last on
More episodes
Broadcasts
- Wed 7 Jun 2023 19:32GMT麻豆社 World Service except East and Southern Africa & West and Central Africa & 麻豆社 Afghan Radio
- Thu 8 Jun 2023 04:32GMT麻豆社 World Service Australasia, Americas and the Caribbean, South Asia & East Asia only
- Thu 8 Jun 2023 12:32GMT麻豆社 World Service except East Asia & South Asia
- Thu 8 Jun 2023 19:32GMT麻豆社 World Service East and Southern Africa & West and Central Africa only
- Sun 11 Jun 2023 01:32GMT麻豆社 World Service
Podcast
-
Health Check
Health issues and medical breakthroughs from around the world.